Venous Thoracic Outlet Syndrome Combined with Brachial Neuritis Caused by Lymphadenopathy after Vaccination for Coronavirus Disease 2019: A Case Report
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Thoracic outlet syndrome (TOS) occurs due to compression of the neurovascular bundle exiting the thoracic outlet, through which the brachial plexus and subclavian vessels pass. Here, we report a case of venous TOS combined with brachial neuritis, which was caused by axillary lymphadenopathy after the first dose of the BNT162b2 vaccine against coronavirus disease 2019 (COVID-19). A 17-year-old female patient presented with left upper extremity swelling and pain after inoculation with the BNT162b2 vaccine in the left deltoid muscle. Contrast-enhanced brachial plexus magnetic resonance imaging revealed severe swelling of the left axillary and subclavian lymph nodes, which lie immediately above the subclavian vein. An electrodiagnostic study revealed left brachial plexopathy, mainly involving the lower trunk with mixed demyelinating and axonal injury. The patient received intravenous steroid pulse therapy and oral steroid therapy. A follow-up examination showed complete recovery of muscle strength and function, pain, and swelling in the left upper extremity within 3 months after vaccination against COVID-19.
Abstract
Thoracic outlet syndrome (TOS) occurs due to compression of the neurovascular bundle exiting the thoracic outlet, through which the brachial plexus and subclavian vessels pass. Here, we report a case of venous TOS combined with brachial neuritis, which was caused by axillary lymphadenopathy after the first dose of the BNT162b2 vaccine against coronavirus disease 2019 (COVID-19). A 17-year-old female patient presented with left upper extremity swelling and pain after inoculation with the BNT162b2 vaccine in the left deltoid muscle. Contrast-enhanced brachial plexus magnetic resonance imaging revealed severe swelling of the left axillary and subclavian lymph nodes, which lie immediately above the subclavian vein. An electrodiagnostic study revealed left brachial plexopathy, mainly involving the lower trunk with mixed demyelinating and axonal injury. The patient received intravenous steroid pulse therapy and oral steroid therapy. A follow-up examination showed complete recovery of muscle strength and function, pain, and swelling in the left upper extremity within 3 months after vaccination against COVID-19.
참고문헌 (13)
- Masocatto NO, "Thoracic outlet syndrome : a narrative review", Rev Col Bras Cir, 46, pp.e20192243~ (2019)
- Min YG, "Parsonage-turner syndrome following COVID-19 vaccination", J Neurol Neurosurg Psychiatry, 93, pp.1231~1232 (2022)
- Shields LBE, "Parsonage-turner syndrome following COVID-19 vaccination : clinical and electromyographic findings in 6 patients", Case Rep Neurol, 14, pp.58~67 (2022)
- Lehman CD, "Unilateral lymphadenopathy after COVID-19 vaccination : a practical management plan for radiologists across specialties", J Am Coll Radiol, 18, pp.843~852 (2021)
- Van Echo DA, "Thoracic outlet syndrome, supraclavicular adenopathy, Hodgkin's disease", Ann Intern Med, 78, pp.608~609 (1973)
- "Brachial neuritis" (2022)[URL]
- van Eijk JJ, "Evaluation of prednisolone treatment in the acute phase of neuralgic amyotrophy : an observational study", J Neurol Neurosurg Psychiatry, 80, pp.1120~1124 (2009)
- van Alfen N, "Sensory nerve conduction studies in neuralgic amyotrophy", Am J Phys Med Rehabil, 88, pp.941~946 (2009)
- Van Eijk JJ, "Neuralgic amyotrophy : an update on diagnosis, pathophysiology, and treatment", Muscle Nerve, 53, pp.337~350 (2016)
- Kraft GH, "Are fibrillation potentials and positive sharp waves the same? No", Muscle Nerve, 19, pp.216~220 (1996)
- Skowronski DM, "Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine", N Engl J Med, 384, pp.1576~1577 (2021)
- Tsairis P, "Natural history of brachial plexus neuropathy : report on 99 patients", Arch Neurol, 27, pp.109~117 (1972)
- El-Sayed MS, "The incidence and duration of COVID-19 vaccine-related reactive lymphadenopathy on 18F-FDG PET-CT", Clin Med(Lond), 21, pp.e633~e638 (2021)